SweetValueLab
Write for us

Albemarle Corporation — Financial Statements & Ratios

ALB
NYSEBasic MaterialsChemicals - SpecialtyCIK 0000915913albemarle.comAbout ALB
Last close · Oct 16, 202695.48−2.70 (−2.75%)
Market cap$11.3B

Key indicators

Revenue5.9BTTM+18.3% on a year earlier+6.2% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
3.4B 3.6B+6.4%3.1B−12.8%3.3B+6.4%7.3B+120.0%9.6B+31.4%5.4B−44.1%5.1B−4.4%5.9B+18.3%6.1B 6.2B 6.3B
— 6.4% -12.8% 6.4% 120.0% 31.4% -44.1% -4.4% 18.3% 18.9% 1.7% 1.8%
$6.34 $5.02−20.8%$3.52−29.9%$1.06−69.9%$22.84+2054.7%$13.36−41.5%-$11.20−183.8%-$5.76+48.6%$0.26+102.9%$11.29 $10.22 $10.82
Profitability
36.1% 35.0%−1.0 pt31.8%−3.2 pt30.0%−1.8 pt42.0%+12.0 pt12.3%−29.7 pt1.2%−11.2 pt13.0%+11.8 pt23.8%+16.1 pt· · ·
27.0% 18.6%−8.5 pt16.2%−2.4 pt24.0%+7.8 pt33.7%+9.8 pt2.6%−31.1 pt-33.0%−35.7 pt-7.1%+25.9 pt4.3%+25.0 pt· · ·
20.6% 14.9%−5.7 pt12.0%−2.8 pt3.7%−8.3 pt36.7%+33.0 pt16.4%−20.4 pt-21.9%−38.3 pt-9.9%+12.0 pt3.8%+22.4 pt· · ·
19.3% 13.6%−5.8 pt8.8%−4.8 pt2.2%−6.6 pt33.7%+31.5 pt16.7%−17.0 pt-11.8%−28.6 pt-5.4%+6.5 pt— · · ·
Cash
-153.8M -132.4M+13.9%-51.6M+61.1%-609.4M−1081.9%646.2M+206.0%-824.0M−227.5%-983.7M−19.4%692.5M+170.4%1.3B+838.8%· · ·
-4.6% -3.7%+0.9 pt-1.6%+2.0 pt-18.3%−16.7 pt8.8%+27.1 pt-8.6%−17.4 pt-18.3%−9.7 pt13.5%+31.8 pt22.7%+26.4 pt· · ·
144.6M 152.2M+5.3%161.8M+6.3%177.9M+9.9%184.4M+3.7%187.2M+1.5%188.5M+0.7%190.5M+1.1%— · · ·
Balance sheet
0.48x 0.78x+0.30x0.84x+0.06x0.43x−0.41x0.40x−0.02x0.44x+0.04x0.35x−0.09x0.33x−0.02x0.18x−0.17x· · ·
109.46M 106.32M−2.9%106.81M+0.5%116.54M+9.1%117.79M+1.1%117.77M−0.0%117.52M−0.2%117.66M+0.1%136.21M+15.8%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.